210 related articles for article (PubMed ID: 9116717)
41. Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody.
Takeda Y; Takeno M; Iwasaki M; Kobayashi H; Kirino Y; Ueda A; Nagahama K; Aoki I; Ishigatsubo Y
Clin Exp Immunol; 2004 Nov; 138(2):237-44. PubMed ID: 15498032
[TBL] [Abstract][Full Text] [Related]
42. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
43. Anti-dsDNA antibody induces soluble fibronectin secretion by proximal renal tubular epithelial cells and downstream increase of TGF-β1 and collagen synthesis.
Yung S; Ng CY; Ho SK; Cheung KF; Chan KW; Zhang Q; Chau MK; Chan TM
J Autoimmun; 2015 Apr; 58():111-22. PubMed ID: 25666976
[TBL] [Abstract][Full Text] [Related]
44. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
45. Anti-dsDNA antibodies and resident renal cells - Their putative roles in pathogenesis of renal lesions in lupus nephritis.
Yung S; Chan TM
Clin Immunol; 2017 Dec; 185():40-50. PubMed ID: 27612436
[TBL] [Abstract][Full Text] [Related]
46. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity.
Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M
Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429
[TBL] [Abstract][Full Text] [Related]
47. Fn14 Deficiency Ameliorates Anti-dsDNA IgG-Induced Glomerular Damage in SCID Mice.
Wu J; Min X; Wang L; Yang J; Wang P; Liu X; Xia Y
J Immunol Res; 2018; 2018():1256379. PubMed ID: 30648117
[TBL] [Abstract][Full Text] [Related]
48. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.
Yang XW; Tan Y; Yu F; Zhao MH
Nephrol Dial Transplant; 2012 Sep; 27(9):3552-9. PubMed ID: 22700716
[TBL] [Abstract][Full Text] [Related]
49. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.
Renaudineau Y; Croquefer S; Jousse S; Renaudineau E; Devauchelle V; Guéguen P; Hanrotel C; Gilburd B; Saraux A; Shoenfeld Y; Putterman C; Youinou P
Arthritis Rheum; 2006 Aug; 54(8):2523-32. PubMed ID: 16868973
[TBL] [Abstract][Full Text] [Related]
50. Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis.
Dieker J; Schlumberger W; McHugh N; Hamann P; van der Vlag J; Berden JH
Mol Immunol; 2015 Nov; 68(1):20-4. PubMed ID: 26597199
[TBL] [Abstract][Full Text] [Related]
51. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
[TBL] [Abstract][Full Text] [Related]
52. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
53. The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be.
Rekvig OP
Front Immunol; 2019; 10():1104. PubMed ID: 31156647
[TBL] [Abstract][Full Text] [Related]
54. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
Tanaka H; Tsugawa K; Nakahata T; Kudo M; Suzuki K; Ito E
Clin Nephrol; 2005 Jun; 63(6):417-22. PubMed ID: 15960142
[TBL] [Abstract][Full Text] [Related]
55. Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.
Kumar S; Bunting KA; Kalsi J; Hinks JA; Latchman DS; Pearl LH; Isenberg DA
Immunology; 2005 Mar; 114(3):418-27. PubMed ID: 15720443
[TBL] [Abstract][Full Text] [Related]
56. Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity.
Mason LJ; Lambrianides A; Haley JD; Manson JJ; Latchman DS; Isenberg DA; Rahman A
Arthritis Res Ther; 2005; 7(5):R971-83. PubMed ID: 16207338
[TBL] [Abstract][Full Text] [Related]
57. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus.
Richards HB; Satoh M; Shaw M; Libert C; Poli V; Reeves WH
J Exp Med; 1998 Sep; 188(5):985-90. PubMed ID: 9730900
[TBL] [Abstract][Full Text] [Related]
58. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus.
Linnik MD; Hu JZ; Heilbrunn KR; Strand V; Hurley FL; Joh T;
Arthritis Rheum; 2005 Apr; 52(4):1129-37. PubMed ID: 15818711
[TBL] [Abstract][Full Text] [Related]
59. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
[TBL] [Abstract][Full Text] [Related]
60. Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody.
Ravirajan CT; Wang Y; Matis LA; Papadaki L; Griffiths MH; Latchman DS; Isenberg DA
Rheumatology (Oxford); 2004 Apr; 43(4):442-7. PubMed ID: 15024133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
